Arquivos do dia: Outubro 20, 2021
Estudo do CDC | Vacina da Pfizer mostrou 93% de efetividade contra internações por Covid-19 entre crianças de 12 a 18 anos.
20 Out, 2021 | 12:12h
Comentário no Twitter (fio – clique para saber mais)
Vaccination reduced the risk of hospitalization among 12–18-year-olds by 93%, according to a new CDC study. No vaccinated adolescents died or were admitted to the ICU.
— Dr. Tom Frieden (@DrTomFrieden) October 19, 2021
Estudo randomizado | Interferon não melhora os desfechos de adultos internados com COVID-19.
20 Out, 2021 | 12:10hComunicado de imprensa: Interferon does not improve outcomes for hospitalized adults with COVID-19 – NIH News Releases
Estudo de coorte | A efetividade da vacinação heteróloga AstraZeneca (AZ)/mRNA foi mais significativa (68%) do que a vacinação homóloga AZ/AZ (50%) contra Covid-19 sintomática na Suécia.
20 Out, 2021 | 12:08hComentário: High effectiveness of mix-and-match COVID-19 vaccines – UMEA University
Conteúdos relacionados:
A primer on what we know about mixing and matching Covid vaccines.
Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination.
RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects.
Comentário no Twitter
Study from Sweden assessing heterogenous vaccination in 3,445,061 individuals who received AZ as the first dose and either #pfizer, #moderna, or #AZ as second dose showed the following vaccine effectiveness:
AZ/Pfizer- 67%
AZ/Moderna- 79%
AZ/AZ- 50%https://t.co/UN0pey2kJ2— Yan Leyfman, MD (@YLeyfman) October 19, 2021
Deve-se misturar e combinar a dose de reforço da vacina?
20 Out, 2021 | 12:06hShould You Mix and Match Your Booster Shot? – The Atlantic
Conteúdos relacionados:
A primer on what we know about mixing and matching Covid vaccines.
Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination.
RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects.
[Preprint] Estudo observacional no Brasil mostrou que a efetividade ajustada da vacina da J&J foi de 50,9% contra Covid-19 sintomática, 72,9% para internações, 92,5% para admissão em UTI, 88,7% para ventilação mecânica e 90,5% para morte.
20 Out, 2021 | 12:05hCovid-19: nova mutação da variante Delta sob observação atenta no Reino Unido.
20 Out, 2021 | 12:03hCovid-19: New mutation of Delta variant under close watch in UK – BBC
Estratégia da Global Initiative for Asthma (GINA) 2021 – Resumo executivo e racional para mudanças importantes.
20 Out, 2021 | 12:02hRevisão sistemática | Agentes anti-interleucina-13 ou anti-interleucina-4 podem ser adequados para adultos com asma descontrolada moderada/grave que não responderam a outros tratamentos.
20 Out, 2021 | 12:01h
Comentário no Twitter (fio – clique para saber mais)
Lead author David Evans said “Approximately five to ten percent of people with asthma experience symptoms that are severe or difficult-to-treat… [1/3] pic.twitter.com/Nw606oSrX0
— CochraneAirways (@CochraneAirways) October 19, 2021
Sete recomendações de políticas da OMS sobre a construção de sistemas de saúde resilientes.
20 Out, 2021 | 11:59hComunicado de imprensa: WHO’s 7 policy recommendations on building resilient health systems – World Health Organization
Posicionamento científico da OMS: Building health systems resilience for universal health coverage and health security during the COVID-19 pandemic and beyond
Comentário no Twitter (fio – clique para saber mais)
#COVID19 has shown that there can be no lasting economic development without #HealthForAll & protection against health emergencies. Here are WHO’s 7⃣ recommendations on building resilient health systems based on #PrimaryHealthCare & #HealthSecurity.
👉 https://t.co/pp5Gh9BTnz pic.twitter.com/0d021b5ylf
— World Health Organization (WHO) (@WHO) October 19, 2021
Resumo de Política da OMS | A necessidade urgente de se implementar o manejo de sangue do paciente.
20 Out, 2021 | 11:58hThe urgent need to implement patient blood management: policy brief – World Health Organization